Takeda Pharmaceutical Co Ltd
(NYSE:TAK)
$
13.45
-0.11 (-0.81%)
Market Cap: 42.99 Bil
Enterprise Value: 70.33 Bil
PE Ratio: 22.63
PB Ratio: 0.94
GF Score: 79/100 Takeda Pharmaceutical Co Ltd at Jefferies Healthcare Conference (Virtual) Transcript
Jun 02, 2020 / 01:30PM GMT
Release Date Price:
$19.21
Stephen Barker
Jefferies LLC, Research Division - Equity Analyst
So thank you, everybody, for joining us for the fireside chat with Takeda Pharmaceuticals. My name is Stephen Barker, pharmaceutical analyst with Jefferies Japan. We are very lucky to have with us today, Christophe Weber, President and Chief Executive Officer of Takeda; we also have Costa Saroukos, Chief Financial Officer of Takeda; and we're also joined by Sheelagh Cawley-Knopf, Head of the Global Portfolio Strategy at Takeda.
So gentlemen, lady, thank you very much for joining us today.
Questions & Answers
Stephen Barker
Jefferies LLC, Research Division - Equity Analyst
We've only got 25 minutes, so I think we should get straight into the questions. I think 1 of the questions that's on people's minds is COVID-19. Has there been impact on Takeda's business? Christophe, please?
Christophe Weber
Takeda Pharmaceutical Company Limited - President, CEO & Representative Director
Thank you, Stephen, and thank you for the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot